a Mutated ras genes (Ha-, Ki-and N-ras) have been found in a variety of human tumours (Barbacid, 1987) . Although in some tumour types the incidence of mutations is relatively high (Bos, 1989) , the practical value of these findings in cancer diagnosis and/or prognosis has not been established.
Ha-ras gene codon 12 mutation and DNA ploidy in urinary bladder carcinoma Mutated ras genes (Ha-, Ki-and N-ras) have been found in a variety of human tumours (Barbacid, 1987) . Although in some tumour types the incidence of mutations is relatively high (Bos, 1989) , the practical value of these findings in cancer diagnosis and/or prognosis has not been established.
Here we report the detection of a mutation of Ha-ras gene codon 12 in human urinary bladder carcinomas by using the polymerase chain reaction (PCR) and relate these findings to tumour DNA ploidy, a parameter that correlates with clinical behaviour of urothelial tumours (Koss et al., 1989) .
DNA was extracted by standard procedures from 33 fresh tumour samples and amplified by PCR. Primers designed to flank a 63 bp fragment containing codon 12 of the Ha-ras gene (Verlaan-de Vries et al., 1986) were used. DNA of human placenta and of T24, a bladder tumour cell line that has GTC (valine) instead of GGC (glycine) at codon 12 of Ha-ras (Taparowsky et al., 1982) were used as controls. (50 1tl) was layered over the aqueous phase. To rule out extraneous contamination of the reaction mixture, control tubes containing all ingredients, except genomic DNA, were included in all runs. Forty amplification cycles were carried out with an automated thermal cycler (Perkin Elmer) using this thermal profile: 1 min at 94°C, 1 min at 55°C and 3 min at 72°C. Amplification was evaluated by electrophoresis on 3% widerange agarose (Sigma) gels (Figure la). The amplified DNA was screened on nitrocellulose filters for codon 12 substitutions with 32P-labelled oligonucleotides (DuPont) specific for: GLY, SER, CYS, ARG, VAL and ALS (Verlaan-de Vries et al., 1986) . Computer-assisted image analysis of Feulgenstained touchsmears (Czerniak et al., 1987) was used to determine the DNA distribution patterns of the tumours.
A normal (glycine) codon 12 of Ha-ras gene (Barbacid, 1987) was found in all 33 tumour samples examined. The substitution of valine for glycine (G-*T mutation) at codon 12 was clearly evident in 12 tumours, although the signal varied in intensity (Figure lb) . The observed mutation frequency was greater than that reported by using transfection assays and restriction endonuclease analysis of urothelial tumours (e.g. Fujita et al., 1984 Fujita et al., , 1985 . No other codon 12 substitution was seen. The synchronous presence of nonmutated codon 12 in the 12 tumour samples could be due to normal host cells, tumour cells without the mutation or tumours cells in which the mutation was confined to only one allele. The latter two options would reflect the heterogeneity of tumour cells with respect to Ha-ras gene mutations (Mulder et al., 1989) .
Based on DNA distribution patterns ( Figure lc ) the tumours were classified as either diploid or aneuploid (Koss et al., 1989 Ltd., 1990 gene. By contrast, 10 of the 20 aneuploid tumours had valine at codon 12 of Ha-ras gene. As shown in Table I the codon 12 substitution correlated better with DNA ploidy than with histological grading. The conventional histological classification of bladder carcinomas is useful for predicting the clinical behaviour of grade I and grade III tumours (Koss, 1975) . Whereas the former can recur and are typically non-invasive, the latter have a strong propensity to invade and metastasise. The individual behaviour of grade II tumours is not predictable as some of them remain superficial and others may become invasive (Koss, 1975) . From DNA ploidy measurements it has been established that the overwhelming majority of grade I tumours is diploid, that grade III tumours are mostly aneuploid and that grade II tumours can be either diploid or aneuploid (Tribukait et al., 1982) . Moreover, it has also been determined that with few exceptions diploid tumours are unlikely to become invasive and that a large proportion of aneuploid tumours progress to invasive and metastatic carcinomas (Tribukait et al., 1982) . Our results demonstrate that urothelial tumours with aneuploid DNA distribution patterns, hence aggressive clinical potential, frequently have a mutation at codon 12 of Ha-ras gene. Therefore, the detection of a mutated ras gene in bladder tumours may be of value for identifying aggressive variants of urothelial carcinomas. Because of the capability of the PCR to amplify specific DNA sequences from small numbers of cells (Kumar & Barbacid, 1988; Yang et al., 1989) , one can envision that the test could be performed on sediments of voided urines. Similarly, retrospective investigations can be carried out on paraffin-embedded tissues of patients with known clinical outcome. Moreover, further studies of mutations at other codons of Ha-, Ki-and N-ras genes and further clinical follow-up may provide additional information on the relationship of such alterations and the clinical behaviour of bladder tumours.
